SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

Janis A Müller1, Rüdiger Groß1, Carina Conzelmann1

  • 1Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Nature Metabolism
|February 4, 2021
PubMed

Insights

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human pancreatic cells, including insulin-producing beta cells. This infection impairs insulin secretion, potentially contributing to metabolic issues seen in coronavirus disease 2019 (COVID-19).

Area of Science:

  • Endocrinology
  • Virology
  • Pathology

Background:

  • Diabetes can result from virus-associated beta-cell destruction.
  • Clinical data suggest SARS-CoV-2 impairs glucose homeostasis, but direct evidence of pancreatic infection was lacking.

Purpose of the Study:

  • To investigate if SARS-CoV-2 infects human pancreatic cells and affects beta-cell function.
  • To determine the presence of SARS-CoV-2 in pancreatic tissue from COVID-19 patients.

Main Methods:

  • Ex vivo and in vivo studies using human pancreatic cells and islets.
  • Analysis of viral entry proteins, viral replication, and beta-cell function (insulin secretion).
  • Postmortem examination of pancreatic tissue from COVID-19 patients for SARS-CoV-2 presence.

Main Results:

  • SARS-CoV-2 infects human exocrine and endocrine pancreatic cells, including beta-cells, which express viral entry proteins.
  • Infection leads to morphological and transcriptional changes, reduced insulin granules, and impaired glucose-stimulated insulin secretion.
  • SARS-CoV-2 nucleocapsid protein was detected in pancreatic cells of COVID-19 patients.

Conclusions:

  • The human pancreas is a target for SARS-CoV-2 infection.
  • SARS-CoV-2 infection of pancreatic beta-cells may contribute to metabolic dysregulation in COVID-19.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.7K
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
3.7K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
834